Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C097949 |
1,25-dihydroxyvitamin D |
[Dexamethasone co-treated with 1,25-dihydroxyvitamin D] inhibits the reaction [WNT3A protein results in increased expression of ALPL protein] | affects cotreatment|decreases reaction|increases expression | 15270777
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of ALPL protein | decreases expression | 11289319
|
C462031 |
6-(1,1-dimethylallyl)naringenin |
[6-(1,1-dimethylallyl)naringenin binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
C462031 |
6-(1,1-dimethylallyl)naringenin |
fulvestrant inhibits the reaction [[6-(1,1-dimethylallyl)naringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C119737 |
8-prenylnaringenin |
[8-prenylnaringenin binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
C119737 |
8-prenylnaringenin |
8-prenylnaringenin results in increased activity of ALPL protein | increases activity | 16019205
|
C119737 |
8-prenylnaringenin |
8-prenylnaringenin results in increased expression of ALPL mRNA | increases expression | 16019205
|
C119737 |
8-prenylnaringenin |
fulvestrant inhibits the reaction [[8-prenylnaringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ALPL mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of ALPL mRNA | increases expression | 19784758
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ALPL protein | affects expression | 20106945
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of ALPL mRNA | increases expression | 17898587
|
D000537 |
Aluminum Oxide |
Aluminum Oxide results in increased expression of ALPL mRNA | increases expression | 19464052
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ALPL mRNA | affects expression | 16483693
|
C040896 |
AST 120 |
AST 120 results in increased expression of ALPL mRNA | increases expression | 16820376
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALPL mRNA | affects cotreatment|increases expression | 18164116
|
C031463 |
beta-glycerophosphoric acid |
ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid | increases hydrolysis | 18500657
|
C031463 |
beta-glycerophosphoric acid |
[ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid] which results in increased abundance of Phosphates | increases abundance|increases hydrolysis | 18500657
|
C031463 |
beta-glycerophosphoric acid |
beta-glycerophosphoric acid results in increased activity of ALPL protein | increases activity | 18500657
|
C031463 |
beta-glycerophosphoric acid |
beta-glycerophosphoric acid results in increased expression of ALPL mRNA | increases expression | 18500657
|
C031463 |
beta-glycerophosphoric acid |
Levamisole inhibits the reaction [beta-glycerophosphoric acid results in increased activity of ALPL protein] | decreases reaction|increases activity | 18500657
|
C031463 |
beta-glycerophosphoric acid |
Levamisole inhibits the reaction [beta-glycerophosphoric acid results in increased expression of ALPL mRNA] | decreases reaction|increases expression | 18500657
|
C031463 |
beta-glycerophosphoric acid |
ALPL protein results in increased degradation of beta-glycerophosphoric acid | increases degradation | 17383965
|
C031463 |
beta-glycerophosphoric acid |
[ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates | increases abundance|increases degradation | 17383965
|
C031463 |
beta-glycerophosphoric acid |
Diphosphates inhibits the reaction [ALPL protein results in increased degradation of beta-glycerophosphoric acid] | decreases reaction|increases degradation | 17383965
|
C031463 |
beta-glycerophosphoric acid |
Diphosphates inhibits the reaction [[ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates] | decreases reaction|increases abundance|increases degradation | 17383965
|
C095105 |
bexarotene |
bexarotene results in increased expression of ALPL mRNA | increases expression | 16648578
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I results in decreased activity of ALPL protein | decreases activity | 11171635
|
C006780 |
bisphenol A |
[bisphenol A binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of ALPL mRNA | decreases expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased activity of ALPL protein | increases activity | 18436364
|
D002251 |
Carbon Tetrachloride |
phenyl caffeate inhibits the reaction [Carbon Tetrachloride results in increased activity of ALPL protein] | decreases reaction|increases activity | 18436364
|
D004390 |
Chlorpyrifos |
[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein | affects cotreatment|increases expression | 15991261
|
D004390 |
Chlorpyrifos |
Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] | affects cotreatment|decreases reaction|increases expression | 15991261
|
D002857 |
Chromium |
Chromium results in decreased activity of ALPL protein | decreases activity | 16866188
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALPL mRNA | affects cotreatment|affects expression | 17602206
|
C018021 |
cobaltous chloride |
cobaltous chloride results in decreased expression of ALPL mRNA | decreases expression | 16772336
|
D003375 |
Coumestrol |
[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
D003375 |
Coumestrol |
fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ALPL mRNA | decreases expression | 20106945
|
C017160 |
cypermethrin |
[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein | affects cotreatment|increases expression | 15991261
|
C017160 |
cypermethrin |
Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] | affects cotreatment|decreases reaction|increases expression | 15991261
|
C017160 |
cypermethrin |
cypermethrin results in increased activity of ALPL protein | increases activity | 15365239
|
C004742 |
daidzein |
[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
C004742 |
daidzein |
fulvestrant inhibits the reaction [[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D003676 |
Deferoxamine |
Deferoxamine results in decreased expression of ALPL mRNA | decreases expression | 16772336
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with 1,25-dihydroxyvitamin D] inhibits the reaction [WNT3A protein results in increased expression of ALPL protein] | affects cotreatment|decreases reaction|increases expression | 15270777
|
D004052 |
Diethylnitrosamine |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein | affects cotreatment|increases activity | 15548946
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALPL mRNA | affects cotreatment|increases expression | 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALPL mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
Tocotrienols affects the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein] | affects cotreatment|affects reaction|increases activity | 15548946
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of ALPL mRNA | increases expression | 15289156 15591538
|
D011756 |
Diphosphates |
ALPL protein inhibits the reaction [Diphosphates results in increased expression of ANK mRNA] | decreases reaction|increases expression | 17383965
|
D011756 |
Diphosphates |
Diphosphates inhibits the reaction [ALPL protein results in increased degradation of beta-glycerophosphoric acid] | decreases reaction|increases degradation | 17383965
|
D011756 |
Diphosphates |
Diphosphates inhibits the reaction [[ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates] | decreases reaction|increases abundance|increases degradation | 17383965
|
D011756 |
Diphosphates |
Diphosphates results in increased activity of ALPL protein | increases activity | 17383965
|
D011756 |
Diphosphates |
Diphosphates results in increased expression of ALPL mRNA | increases expression | 17383965
|
D011756 |
Diphosphates |
ALPL protein results in increased degradation of Diphosphates | increases degradation | 17383965 18500657
|
D004958 |
Estradiol |
[Estradiol binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
D004958 |
Estradiol |
fulvestrant inhibits the reaction [[Estradiol binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of ALPL mRNA | affects cotreatment|increases expression | 17404688
|
D004958 |
Estradiol |
Estradiol results in increased expression of ALPL mRNA | increases expression | 15289156
|
D004997 |
Ethinyl Estradiol |
VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] | affects cotreatment|affects expression|affects reaction | 12521655
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of ALPL protein | decreases expression | 17240242
|
D015025 |
Zearalenone |
fulvestrant inhibits the reaction [[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D015025 |
Zearalenone |
[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
C017690 |
fenvalerate |
fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein] | decreases reaction|increases activity | 16326432
|
C017690 |
fenvalerate |
fenvalerate results in increased activity of ALPL protein | increases activity | 15696646
|
D015073 |
2-Acetylaminofluorene |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein | affects cotreatment|increases activity | 15548946
|
D015073 |
2-Acetylaminofluorene |
Tocotrienols affects the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein] | affects cotreatment|affects reaction|increases activity | 15548946
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[6-(1,1-dimethylallyl)naringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[8-prenylnaringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[Estradiol binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[Genistein binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D019833 |
Genistein |
fulvestrant inhibits the reaction [[Genistein binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
D019833 |
Genistein |
[Genistein binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
D019833 |
Genistein |
Genistein results in increased expression of ALPL mRNA | increases expression | 15289156
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased activity of ALPL protein | decreases activity | 11171635
|
C513449 |
icarisid II |
icarisid II results in increased expression of ALPL mRNA | increases expression | 17764702
|
C499403 |
icaritin |
icaritin results in increased expression of ALPL mRNA | increases expression | 17764702
|
C028904 |
isoproturon |
[Lindane co-treated with isoproturon] results in decreased activity of ALPL protein | affects cotreatment|decreases activity | 11180283
|
C028904 |
isoproturon |
[Lindane co-treated with isoproturon] results in increased expression of ALPL protein | affects cotreatment|increases expression | 11180283
|
D001556 |
Lindane |
[Lindane co-treated with isoproturon] results in decreased activity of ALPL protein | affects cotreatment|decreases activity | 11180283
|
D001556 |
Lindane |
[Lindane co-treated with isoproturon] results in increased expression of ALPL protein | affects cotreatment|increases expression | 11180283
|
D001556 |
Lindane |
Lindane results in increased activity of ALPL protein | increases activity | 11180283
|
D001556 |
Lindane |
Lindane results in increased expression of ALPL protein | increases expression | 11180283
|
C030814 |
menatetrenone |
menatetrenone results in increased activity of ALPL protein | increases activity | 11113387
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of ALPL mRNA | increases expression | 12634122
|
C005273 |
naringenin |
fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | affects binding|decreases reaction|increases activity | 12650720
|
C005273 |
naringenin |
[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
C025256 |
nonylphenol |
[nonylphenol binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
D016912 |
Levonorgestrel |
VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] | affects cotreatment|affects expression|affects reaction | 12521655
|
C474055 |
octylphenol |
[octylphenol binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
C084656 |
paricalcitol |
[Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA | affects cotreatment|increases expression | 17715259
|
D026023 |
Permethrin |
Permethrin inhibits the reaction [Progesterone results in increased activity of ALPL protein] | decreases reaction|increases activity | 16326432
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ALPL mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ALPL mRNA | increases expression | 19482888
|
C500434 |
phenyl caffeate |
phenyl caffeate inhibits the reaction [Carbon Tetrachloride results in increased activity of ALPL protein] | decreases reaction|increases activity | 18436364
|
D010710 |
Phosphates |
[ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid] which results in increased abundance of Phosphates | increases abundance|increases hydrolysis | 18500657
|
D010710 |
Phosphates |
[ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates | increases abundance|increases degradation | 17383965
|
D010710 |
Phosphates |
Diphosphates inhibits the reaction [[ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates] | decreases reaction|increases abundance|increases degradation | 17383965
|
D010710 |
Phosphates |
ALPL protein results in increased chemical synthesis of Phosphates | increases chemical synthesis | 18500657
|
D010758 |
Phosphorus |
[Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA | affects cotreatment|increases expression | 17715259
|
D048789 |
Phytoestrogens |
Phytoestrogens results in increased activity of ALPL protein | increases activity | 16019205
|
D048789 |
Phytoestrogens |
Phytoestrogens results in increased expression of ALPL mRNA | increases expression | 16019205
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ALPL mRNA | increases expression | 20059764
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ALPL protein | increases expression | 19176532
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of ALPL mRNA] | increases expression|increases reaction | 20059764
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of ALPL protein] | increases expression|increases reaction | 19176532
|
D010936 |
Plant Extracts |
[Plant Extracts binds to ESR1 protein] which results in increased activity of ALPL protein | affects binding|increases activity | 12650720
|
D010936 |
Plant Extracts |
Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] | affects cotreatment|decreases reaction|increases expression | 15991261
|
D011192 |
Potassium Dichromate |
Potassium Dichromate results in decreased activity of ALPL protein | decreases activity | 16866188
|
D011374 |
Progesterone |
fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein] | decreases reaction|increases activity | 16326432
|
D011374 |
Progesterone |
Permethrin inhibits the reaction [Progesterone results in increased activity of ALPL protein] | decreases reaction|increases activity | 16326432
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of ALPL mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased activity of ALPL protein | increases activity | 16326432
|
D011374 |
Progesterone |
Progesterone results in increased expression of ALPL mRNA | increases expression | 17404688
|
D020845 |
Selective Estrogen Receptor Modulators |
Selective Estrogen Receptor Modulators results in decreased expression of ALPL protein | decreases expression | 17240242
|
D012906 |
Smoke |
Smoke results in decreased expression of ALPL protein | decreases expression | 18035141
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of ALPL mRNA | affects expression | 20106945
|
D007978 |
Levamisole |
Levamisole inhibits the reaction [beta-glycerophosphoric acid results in increased activity of ALPL protein] | decreases reaction|increases activity | 18500657
|
D007978 |
Levamisole |
Levamisole inhibits the reaction [beta-glycerophosphoric acid results in increased expression of ALPL mRNA] | decreases reaction|increases expression | 18500657
|
D007978 |
Levamisole |
Levamisole results in decreased activity of ALPL protein | decreases activity | 18500657
|
D013853 |
Thioacetamide |
Thioacetamide results in decreased expression of ALPL mRNA | decreases expression | 19784758
|
C009495 |
titanium dioxide |
titanium dioxide results in increased expression of ALPL mRNA | increases expression | 19464052
|
D024508 |
Tocotrienols |
Tocotrienols affects the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein] | affects cotreatment|affects reaction|increases activity | 15548946
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014212 |
Tretinoin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [Tunicamycin results in increased degradation of ALPL protein] | decreases reaction|increases degradation | 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of ALPL protein | increases activity | 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of and results in increased N-linked glycosylation of ALPL protein | increases expression|increases N-linked glycosylation | 10567916
|
D014212 |
Tretinoin |
Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 10567916
|
D014212 |
Tretinoin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of ALPL protein | increases activity | 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ALPL mRNA | increases expression | 16604517
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of and results in increased N-linked glycosylation of ALPL protein | increases expression|increases N-linked glycosylation | 10567916
|
D014212 |
Tretinoin |
Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 10567916
|
D014212 |
Tretinoin |
EGF protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 11171635
|
D014212 |
Tretinoin |
IL1B protein promotes the reaction [Tretinoin results in increased expression of ALPL mRNA] | increases expression|increases reaction | 11171635
|
D014212 |
Tretinoin |
IL1B protein promotes the reaction [Tretinoin results in increased expression of and results in increased activity of ALPL protein] | increases activity|increases expression|increases reaction | 11171635
|
D014212 |
Tretinoin |
IL2 protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 11171635
|
D014212 |
Tretinoin |
IL4 protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 11171635
|
D014212 |
Tretinoin |
IL5RA protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 11171635
|
D014212 |
Tretinoin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of ALPL protein | increases activity | 11171635 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ALPL mRNA | increases expression | 10567916
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of and results in increased N-linked glycosylation of ALPL protein | increases expression|increases N-linked glycosylation | 10567916
|
D014212 |
Tretinoin |
Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 10567916
|
D014415 |
Tunicamycin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014415 |
Tunicamycin |
Tretinoin inhibits the reaction [Tunicamycin results in increased degradation of ALPL protein] | decreases reaction|increases degradation | 10567916
|
D014415 |
Tunicamycin |
Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 10567916
|
D014415 |
Tunicamycin |
Tunicamycin results in increased degradation of ALPL protein | increases degradation | 10567916
|
D014415 |
Tunicamycin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014415 |
Tunicamycin |
Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 10567916
|
D014415 |
Tunicamycin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | decreases reaction|increases activity | 10567916
|
D014415 |
Tunicamycin |
Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] | decreases reaction|increases activity | 10567916
|
C104536 |
xanthohumol |
xanthohumol results in increased activity of ALPL protein | increases activity | 16019205
|
C104536 |
xanthohumol |
xanthohumol results in increased expression of ALPL mRNA | increases expression | 16019205
|
C028541 |
zirconium oxide |
zirconium oxide results in increased expression of ALPL mRNA | increases expression | 19464052
|
C088658 |
zoledronic acid |
TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein] | affects reaction|decreases activity | 18496637
|
C088658 |
zoledronic acid |
zoledronic acid results in decreased activity of ALPL protein | decreases activity | 18496637
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
6.00 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.00 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.86 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.23 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
3.84 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.48 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
4.78 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
8.22 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
8.22 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
8.22 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
8.22 | 11473722 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
12.32 | 10737359 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
12.32 | 3712494 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
12.32 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
12.32 | 10737359 6695378 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.29 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
19.16 | 19052882 17162532 19061943 18056438 16434500 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
19.16 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
19.16 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
19.16 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
10.72 | 16611668 11874814 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
10.72 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
10.72 | 12661182 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.04 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Plant Extracts |
2.83 | 16962711 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.81 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.34 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.13 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
2.78 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
18.06 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
18.06 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Plant Extracts |
18.06 | 14686799 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
18.06 | 18706406 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
18.06 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.06 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.09 | 16456186 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.18 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.53 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.73 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.30 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.81 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
16.81 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
16.81 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
16.81 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.08 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.28 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.31 | 19442620 17312309 11697798 15867366 16121404 16778634 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
7.70 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
7.70 | 18404659 15845617 16769263 11869084 18496637 8053405 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.62 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.58 | 15845082 15665606 15380490 |
MESH:D002545 |
Brain Ischemia |
|
Plant Extracts |
4.03 | 16041641 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
12.26 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
12.26 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
12.26 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Deferoxamine |
12.26 | 15993339 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
12.26 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
12.26 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
12.26 | 17261762 12948864 14630087 17289903 16675129 17018787 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
12.26 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
12.26 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
12.26 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Phytoestrogens |
12.26 | 17158751 17176212 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
12.26 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
12.26 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
12.26 | 16873071 16443354 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
12.26 | 18695136 16096432 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.89 | 16813970 |
MESH:D002057 |
Burns, Chemical |
|
Plant Extracts |
4.62 | 9625245 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.76 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.10 | 10355542 16192424 15721981 18705752 16227642 16050911 15700767 16124888 15673190 16097048 3786805 16011737 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.24 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.44 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
27.89 | 10737359 3084413 3581430 17761372 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
27.89 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
27.89 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
27.89 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
27.89 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
27.89 | 19822196 19701751 20101231 18393292 20524982 17428255 17162532 20935162 20007298 19335982 16540662 20084675 18691550 19539802 16681979 17173139 18056438 3581430 18494052 19394651 20432363 19919837 11831363 19052882 16779866 19171122 20512989 17761372 18978308 3084413 16830150 16288022 21159647 18785209 19107877 19519916 16698587 17978847 19383236 18506893 20727157 17138121 20214788 18788625 10672840 16878318 10737359 18210153 16502159 16807293 16935385 16328049 19208518 17055752 20514400 18665156 18971187 19418558 16569478 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
27.89 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
27.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
27.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
27.89 | 20935162 1701930 6705139 20007298 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Plant Extracts |
27.89 | 18834353 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
27.89 | 17997003 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
27.89 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.29 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.04 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
5.04 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
5.52 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
5.52 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.06 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Plant Extracts |
5.53 | 17645561 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.53 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
9.58 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
9.58 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Phytoestrogens |
9.58 | 16862667 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.71 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.71 | 17460283 |
MESH:D002418 |
Cattle Diseases |
|
Levamisole |
5.72 | 14651886 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.70 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.70 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
15.70 | 17174075 2727394 7505956 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.70 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
15.70 | 2727394 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.57 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.89 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
12.65 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
12.65 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
12.65 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
19.58 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
19.58 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
19.58 | 16919318 11677210 17110522 16105132 15861022 17681005 17333356 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
19.58 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
19.58 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.44 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.59 | 16354765 8697196 12621046 15668235 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.59 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.03 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
3.35 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.35 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Levamisole |
4.11 | 15148649 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
Phytoestrogens |
4.71 | 17367797 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.53 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Permethrin |
4.53 | 19861644 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.53 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.53 | 14991402 10589399 9664655 9125849 9142499 8800419 9211117 17551590 16925845 9224671 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.89 | 16002989 12952375 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
11.15 | 18759878 11906362 11298694 8156756 12868966 14531868 8970840 2524372 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
11.15 | 11298694 15059100 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
11.15 | 12438553 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Potassium Dichromate |
11.15 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.05 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
7.52 | 3621924 2952479 |
MESH:D003877 |
Dermatitis, Contact |
|
Permethrin |
7.52 | 14617103 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
8.31 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
8.31 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
8.31 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
8.31 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.19 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Plant Extracts |
7.19 | 19706694 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.81 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.06 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.68 | 7440962 18648102 6679447 6482804 16192314 11289319 9328219 18289764 1440618 9653073 8291058 18692083 9022650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.68 | 16485898 17522070 16177239 11421492 19164858 14725611 16109766 16781746 10774834 12958197 16393943 10915739 17562736 12705907 12392966 14986274 19923254 18071297 16081117 11287661 2444490 11834606 19085960 16227642 15619225 17906064 15968718 14550746 12594235 18713872 19420014 10663392 19370779 19416960 12540782 11743745 12153990 19739265 11739529 11461765 11529661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.68 | 15027814 15998439 7179309 9327722 6884620 11566570 2869522 7120509 10092053 19336974 19085960 3786805 15968718 4309450 16177239 6623471 16227642 3732212 7440962 17522070 21278145 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
11.68 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.68 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
11.68 | 12963478 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.38 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.22 | 11462148 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
4.68 | 16487989 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.35 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.79 | 12438553 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
15.11 | 8273558 |
MESH:D004487 |
Edema |
|
Dexamethasone |
15.11 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
15.11 | 12083418 |
MESH:D004487 |
Edema |
|
Plant Extracts |
15.11 | 12787963 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.11 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.58 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.58 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
6.83 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
6.83 | 17692515 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
16.33 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
16.33 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Phytoestrogens |
16.33 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
22.76 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
22.76 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
22.76 | 18566989 19148513 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
22.76 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Phytoestrogens |
22.76 | 16543667 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
22.76 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
6.89 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
6.89 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Plant Extracts |
4.97 | 15268973 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.43 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.17 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
5.59 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Plant Extracts |
5.59 | 19439326 19700373 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.95 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.57 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.32 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.35 | 14972507 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.40 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
1.90 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.02 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.02 | 16938888 9664655 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.01 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
22.62 | 15959796 17595544 12795759 12631006 16239168 16045604 61145 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.62 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
22.62 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
22.62 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.62 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Plant Extracts |
22.62 | 15975614 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.19 | 16534752 15751030 16611131 16002989 16513791 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.13 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.77 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.30 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
15.57 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.57 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.57 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
15.57 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
2.96 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.25 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.52 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
5.58 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
5.58 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.39 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.88 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.69 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.44 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.14 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.14 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.68 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Plant Extracts |
5.68 | 18097624 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
4.60 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
3.78 | 6705139 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.72 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.70 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
3.94 | 15929193 18665440 17276928 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
17.03 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
17.03 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
17.03 | 16487989 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
17.03 | 16456712 |
MESH:D006529 |
Hepatomegaly |
|
fenvalerate |
15.19 | 15602828 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
15.19 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.19 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.19 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.78 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.32 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Plant Extracts |
3.93 | 10715843 |
MESH:D015658 |
HIV Infections |
|
Plant Extracts |
3.28 | 12878215 |
MESH:D019584 |
Hot Flashes |
|
8-prenylnaringenin |
13.31 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
13.31 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Plant Extracts |
13.31 | 16566672 17454163 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.33 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
9.86 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
9.86 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
9.86 | 16769263 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.83 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.41 | 18089816 19622757 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.88 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.57 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Plant Extracts |
3.87 | 16484555 |
MESH:D006949 |
Hyperlipidemias |
|
Plant Extracts |
3.83 | 15268973 15975614 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
8.57 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
8.57 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
9.70 | 10903974 |
MESH:D006973 |
Hypertension |
|
daidzein |
9.70 | 17169123 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
9.70 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.70 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.40 | 15338365 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.48 | 12669777 |
OMIM:146300 |
HYPOPHOSPHATASIA, ADULT |
marker/mechanism |
|
| |
OMIM:241510 |
HYPOPHOSPHATASIA, CHILDHOOD |
marker/mechanism |
|
| |
OMIM:241500 |
HYPOPHOSPHATASIA, INFANTILE |
marker/mechanism |
|
| |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.97 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.97 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.72 | 15869954 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.69 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.81 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Coumestrol |
12.15 | 16892005 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
12.15 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
12.15 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Phytoestrogens |
12.15 | 16731787 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
14.59 | 8273558 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
14.59 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
14.59 | 18785209 |
MESH:D007249 |
Inflammation |
|
Plant Extracts |
14.59 | 15997105 16366677 12787963 19332304 |
MESH:D007249 |
Inflammation |
|
Progesterone |
14.59 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.59 | 12878042 12200463 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
10.84 | 15189238 |
MESH:D007299 |
Insect Bites and Stings |
|
Permethrin |
10.84 | 12749493 15189238 12971516 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
9.46 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
9.46 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
9.46 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.09 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Plant Extracts |
4.00 | 12628509 12584176 12351151 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.30 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.83 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.83 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.73 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.34 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
14.34 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.34 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.34 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Potassium Dichromate |
14.34 | 19665454 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.02 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.02 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
13.02 | 14681315 15003126 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.02 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.39 | 17184923 |
MESH:D007938 |
Leukemia |
|
Genistein |
8.33 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Permethrin |
8.33 | 12937054 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
8.33 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.14 | 18089816 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.07 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Deferoxamine |
3.79 | 20368581 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.79 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.66 | 19029980 17712046 19225113 16891316 17361223 9834237 16935935 16788101 12679006 17294898 19075265 17649720 17506722 16823087 17301526 16331271 17217047 17368321 19642359 17339181 16140955 16766008 19035177 15748426 17107899 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.78 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
12.22 | 16239168 17157831 21278145 17334410 16221502 17174718 16943688 11903743 11408273 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
12.22 | 18522880 18665156 18407596 20032147 19638242 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
12.22 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Plant Extracts |
12.22 | 17157831 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.72 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
15.23 | 18472332 16011737 16015684 15996030 11481614 15362042 18054572 18339082 18412020 16033810 17805973 18205269 18210741 16097048 18395914 12741479 17481882 15123356 17922224 17900296 12649538 13678700 15931870 18279442 16116963 10355542 18705752 15052691 15893842 17721639 14620537 18429990 15057751 16027843 18472094 14716833 12666154 18263696 12445418 15959796 14512876 18420326 18481824 12586293 14716496 18395095 20821823 12609069 12389079 17976157 14724832 17714472 16248980 15818738 14748882 17557913 17944888 12667390 17565644 15876570 18277467 18376398 17698563 12632512 15338365 17766677 17869086 18418968 18317297 18156304 18006644 17761835 16638106 17708605 18166357 12445421 15370692 17631135 17823541 15730626 15650968 12546737 15925388 12958196 16136751 12898905 15673190 17640975 12632514 16192424 18251166 18187930 17525996 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
15.23 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
15.23 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
15.23 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
naringenin |
15.23 | 14709902 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
15.23 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Plant Extracts |
15.23 | 15479170 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
15.23 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
15.23 | 16343077 15078482 17355460 11682029 18031379 15075984 12891558 18032466 15716488 17629604 15158331 18458672 12085344 15095483 18606216 15316131 18380797 16126171 17292413 12531686 15288472 12679928 16097051 16098781 18395095 14739098 17050028 11481614 15362042 15474484 16511523 11172339 15465738 18295389 12557150 18416461 18615449 15288473 10677585 15334695 17127702 16248980 12175628 18263696 16489207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
15.23 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
marker/mechanism |
|
| 19784758 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
25.23 | 16611625 19784758 12587719 19460945 11587558 12969438 16610002 19014921 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
25.23 | 16964402 16246199 17285989 15830285 15720792 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
25.23 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
25.23 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
25.23 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
25.23 | 1715830 |
MESH:D008107 |
Liver Diseases |
|
naringenin |
25.23 | 16945181 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
25.23 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Plant Extracts |
25.23 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
25.23 | 15158337 18374380 16337175 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.48 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
12.69 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
12.69 | 14706259 16899240 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
12.69 | 17276928 15313186 12479984 15633222 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
30.79 | 14678523 18001218 10737359 10672840 11376686 16273603 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
30.79 | 15890375 18177683 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
30.79 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
30.79 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
30.79 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
30.79 | 19642983 19996281 20101389 20118626 19090486 18978307 2862719 20583210 2422723 16942905 19294768 20501860 19551842 19255062 18648771 21167192 18977376 19427195 21071580 15885732 15175105 19073162 19254457 19850985 20137499 20434301 12771043 19833225 21278145 20405173 20492335 18754104 9163691 18644402 21047994 19499222 19812893 19690152 12112319 10737359 19638242 20452335 19426721 19256749 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
30.79 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
30.79 | 8742319 15975961 21047994 19073162 19482888 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
30.79 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Plant Extracts |
30.79 | 19168119 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
30.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
24.94 | 1399818 6150874 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
24.94 | 1399818 3712494 598648 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
24.94 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
24.94 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
24.94 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
24.94 | 19126423 3124819 18308698 18079962 18282651 18544905 19004024 16267830 18164116 18093689 16842330 18775883 18253720 17942915 17854601 19539802 21159647 19009564 19519916 2563599 9362446 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
24.94 | 18308698 1399818 17172636 2563599 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
24.94 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
10.64 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
10.64 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
10.64 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
10.64 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
10.64 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Plant Extracts |
10.64 | 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Smoke |
10.64 | 11091918 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.64 | 19555203 11884234 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.45 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
2.96 | 15700306 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.46 | 11161223 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.80 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
13.72 | 19196723 19196722 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.72 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.72 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
13.72 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
13.72 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.77 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.46 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.84 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.88 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.74 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Phosphates |
4.34 | 12686366 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.42 | 16675582 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.07 | 16801185 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.19 | 17671175 |
MESH:D008881 |
Migraine Disorders |
|
Phytoestrogens |
4.47 | 12224599 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
6.05 | 16118317 15867202 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
6.05 | 18089719 16996129 19621390 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.83 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
6.05 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.05 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
4.51 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
4.51 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.45 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
10.96 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
10.96 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
10.96 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.78 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
7.62 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
7.62 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
7.62 | 15867366 17312309 19139120 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
14.63 | 15313581 |
MESH:D009369 |
Neoplasms |
|
fenvalerate |
14.63 | 2895627 |
MESH:D009369 |
Neoplasms |
|
Lindane |
14.63 | 16818664 12807735 |
MESH:D009369 |
Neoplasms |
|
naringenin |
14.63 | 15185748 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.63 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.63 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
9.28 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Phytoestrogens |
9.28 | 16912569 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.04 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.73 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.69 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
29.71 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
29.71 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
29.71 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
29.71 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
29.71 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
29.71 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
5.59 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
5.59 | 9142499 |
MESH:D019954 |
Neurobehavioral Manifestations |
|
Plant Extracts |
4.50 | 17168769 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
6.25 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
6.25 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.40 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.67 | 15081274 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.97 | 20558911 |
MESH:D009765 |
Obesity |
|
Plant Extracts |
3.97 | 19056576 20132043 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
2.81 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.30 | 3988306 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
4.67 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.66 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
9.47 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
9.47 | 12665316 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
9.47 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.44 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.29 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.94 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
8.94 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.94 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.94 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
8.02 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
8.02 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
8.02 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
6.77 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
6.77 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
6.77 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Phytoestrogens |
4.60 | 17269527 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.04 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
7.21 | 7296757 |
MESH:D010212 |
Papilloma |
|
Plant Extracts |
7.21 | 15173996 16517061 |
MESH:D010243 |
Paralysis |
|
fenvalerate |
5.30 | 8952708 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.53 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.76 | 6228378 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.46 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.99 | 16977796 15687265 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.89 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
11.81 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
11.81 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
11.81 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.11 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
12.26 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
12.26 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
12.26 | 11118676 11896295 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.45 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.45 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.57 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Coumestrol |
2.57 | 16921512 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.57 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.57 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.57 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
2.57 | 12661182 14688026 |
MESH:D011471 |
Prostatic Neoplasms |
|
Phytoestrogens |
2.57 | 16921512 |
MESH:D011471 |
Prostatic Neoplasms |
|
Plant Extracts |
2.57 | 17804756 14666653 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
2.57 | 19103299 12438248 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
2.96 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.69 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
7.69 | 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
3.78 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.94 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.09 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.09 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.00 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.38 | 18379247 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
3.96 | 16611668 11874814 17119214 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.17 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.18 | 16611668 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.83 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.45 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.56 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
4.27 | 16121404 |
MESH:D012640 |
Seizures |
|
Lindane |
4.68 | 15475178 7539098 12842176 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
4.68 | 3137016 4039156 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.12 | 6407741 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.37 | 6418539 |
MESH:D012878 |
Skin Neoplasms |
|
Plant Extracts |
7.29 | 16517061 15173996 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
7.29 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
7.29 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
9.35 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.35 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.58 | 15862959 16503802 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.63 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.19 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.19 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
5.63 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Plant Extracts |
5.63 | 18193104 12787963 15255614 17135157 18237397 |
MESH:D013322 |
Strongyloidiasis |
|
Levamisole |
6.21 | 14651886 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.29 | 16045194 16684133 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Plant Extracts |
4.77 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.97 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.56 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.19 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.58 | 1399818 6582329 7505956 3712494 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
12.58 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
12.58 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.58 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.97 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.17 | 16051514 |
MESH:D014202 |
Tremor |
|
fenvalerate |
4.86 | 8952708 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.75 | 16040207 |
MESH:D014511 |
Uremia |
|
AST 120 |
6.85 | 17057375 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
6.52 | 15867355 15289314 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.52 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
6.52 | 16712894 17306315 16452187 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
5.15 | 16487989 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.34 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
7.46 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
7.46 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
11.45 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
11.45 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
7.27 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.27 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.90 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
9.40 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.40 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.75 | 16002989 16513791 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.88 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
8.68 | 14671159 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
8.68 | 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Plant Extracts |
4.07 | 18097624 |
MESH:D020257 |
Ventricular Remodeling |
|
Plant Extracts |
4.62 | 18097624 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.39 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.53 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.36 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Plant Extracts |
3.67 | 19894650 20213670 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.73 | 17120751 |